NIB HOLDINGS LIMITED (NHF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NHF

NHF - NIB HOLDINGS LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX200 | ASX300 | ALL-ORDS

nib Holdings is an Australian healthcare fund. Originally established in 1952 to provide health insurance to BHP steel workers, it became a listed company in 2007.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$7.02

01 Jul
2025

-0.060

OPEN

$6.99

-0.85%

HIGH

$7.09

1,227,967

LOW

$6.89

TARGET
$6.968 -0.7% downside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NOL . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
NHF: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 38.3 42.2 xxx
DPS (cps) xxx 29.0 27.9 xxx
EPS Growth xxx - 7.5% 10.2% xxx
DPS Growth xxx 3.6% - 3.9% xxx
PE Ratio xxx N/A 17.0 xxx
Dividend Yield xxx N/A 3.9% xxx
Div Pay Ratio(%) xxx 75.7% 66.0% xxx

Dividend yield today if purchased 3 years ago: 3.94%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 4.03

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 05/09 - ex-div 14c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic 32.919.835.229.641.438.3
DPS All 23.014.024.022.028.029.0
Sales/Revenue 2,446.4 M2,541.3 M2,597.6 M2,793.7 M3,121.7 M3,413.9 M
Book Value Per Share 135.2129.4151.1157.1200.3212.5
Net Operating Cash Flow 184.5 M211.6 M108.7 M337.6 M246.7 M257.1 M
Net Profit Margin 6.12 %3.55 %6.20 %4.86 %6.33 %5.47 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed 25.55 %14.96 %25.18 %19.25 %23.42 %18.69 %
Return on Invested Capital 18.33 %10.33 %17.24 %13.61 %17.39 %14.48 %
Return on Assets 9.91 %5.46 %9.20 %7.34 %9.56 %8.67 %
Return on Equity 25.55 %14.96 %25.18 %19.25 %23.42 %18.69 %
Return on Total Capital 27.72 %15.51 %24.29 %19.86 %26.08 %21.86 %
Free Cash Flow ex dividends 60.4 M104.6 M43.7 M221.5 M125.4 M109.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt 1 M8 M9 M9 M9 M8 M
Long Term Debt 233 M307 M281 M303 M283 M299 M
Total Debt 234 M316 M290 M312 M292 M307 M
Goodwill - Gross 227 M227 M219 M236 M365 M371 M
Cash & Equivalents - Generic 165 M198 M214 M207 M243 M275 M
Price To Book Value 5.673.564.314.704.223.46

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex 28.6 M27.0 M23.6 M26.6 M52.3 M48.6 M
Capex % of Sales 1.17 %1.06 %0.91 %0.95 %1.68 %1.42 %
Cost of Goods Sold ------
Selling, General & Admin. Exp & Other 388 M448 M360 M506 M597 M184 M
Research & Development ------
Investments - Total 818 M838 M878 M1,018 M1,077 M1,091 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

5

xxxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

07/05/2025

3

Neutral

$6.90

-1.71%

Citi suggests the downgrade in nib Holdings' 2H25 outlook for New Zealand underlying operating profit to an operating FY25 loss is not a complete surprise given elevated claims inflation.

The broker now forecasts FY25 underlying profit of $236m, at the low end of the company's $235-250m guidance range.

FY25 EPS forecast cut by -4% and FY26 by -2%. Neutral. Target cut to $6.90 from $6.95.

FORECAST
Citi forecasts a full year FY25 dividend of 28.50 cents and EPS of 42.90 cents.
Citi forecasts a full year FY26 dividend of 30.50 cents and EPS of 49.30 cents.

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxxxxxxx xx xxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

13/05/2025

2

Overweight

$7.20

2.56%

Jarden retains an Overweight rating on Nib Holdings and raises the target price to $7.20 from $6.95, citing margin strength in the Australian health insurance (ARHI) segment.

Despite persistent inflation in New Zealand, management reaffirmed FY25 guidance, which Jarden interprets as confidence in ARHI offsetting regional weaknesses.

The broker forecasts ARHI gross margins will rise to 17.7% in FY25, with net margins expected to reach 7.3% on the back of benign claims inflation and cost-out benefits.

ARHI unit sales momentum is strong, highlights Jarden, with management noting the highest sales in a decade despite premium increases.

In contrast, Jarden sharply downgrades expectations for the New Zealand business due to claims inflation of 26% and projected 2H25 losses, revising FY25 NZ earnings to -$14m from $9m prior.

FORECAST
Jarden forecasts a full year FY25 dividend of 28.00 cents and EPS of 36.40 cents.
Jarden forecasts a full year FY26 dividend of 31.00 cents and EPS of 45.00 cents.
Access Extra Coverage Research History >

NHF STOCK CHART

FNArena News on NHF

1
ASX100 vs ASX300: Key Differences And What Investors Should Know

Jun 30 2025 - FYI
2
Australia’s Digital Infrastructure Opportunity

Jun 23 2025 - Australia
3
Rudi’s View: Is Buy The Dip Changing Markets?

May 21 2025 - Rudi's View
4
Australian Broker Call *Extra* Edition – May 13, 2025

May 13 2025 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – May 12, 2025

May 12 2025 - Daily Market Reports

Latest Insurance News

1
Insurers To Pamper Shareholders With Buybacks

Jan 24 2025 - Australia
2
IAG Shares Breaking Out

Jan 21 2025 - Technicals
3
ESG Focus: The Little Big Things – 21-11-2024

Nov 21 2024 - ESG Focus
4
New-Look Suncorp Ready To Rumble

Nov 14 2024 - Australia
5
Steadfast’s Long March

Jul 02 2024 - Australia
6
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals
7
SMSFundamentals: Older People Are Life Insurers’ Future Challenge

Oct 26 2023 - SMSFundamentals
8
Australian Insurers And The Weather

Oct 19 2023 - Feature Stories
9
Steadfast Group’s US Entry Full Of Promise

Oct 11 2023 - Australia
10
Pros And Cons Of Insurance Companies

Aug 02 2023 - Australia